| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non-Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L) |
| 掲載誌名 | 正式名：Clinical lung cancer 略 称：Clin Lung Cancer ISSNコード：15257304 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 23(3),pp.e257-e263 |
| 著者・共著者 | Haratake N, Hayashi H, Shimokawa M, Nakano Y, Azuma K, Oki M, Ota K, Yoshioka H, Sakamoto T, Yamamoto N, Nakagawa K, Seto T. |
| 発行年月 | 2022/05 |
| DOI | 10.1016/j.cllc.2021.10.007 |
| PMID | 34887192 |